Biosim Funding & Investors

Biosim will accelerate the drug discovery process many-fold through its platform that combines cutting-edge ideas from scientific computing, AI and quantum chemistry. Our aim is to reduce the timescale of small-molecule drug discovery projects from years to months and eventually to weeks. See our openings if you want to be part of a world-class R&D team, led by our founder, Garegin Papoian, Monroe Martin Professor of Chemistry, at the University of Maryland.